Prospective randomized controlled trial to compare operative methods in early-stage cervical cancer
Not Applicable
Recruiting
- Conditions
- C53Malignant neoplasm of cervix uteri
- Registration Number
- DRKS00006068
- Lead Sponsor
- Klinik für GynäkologieCharité Campus Charité Mitte
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Patients with cervical cancer, Squamous Cell Carcinoma and Adenocarcinoma
Cervical Cancer FIGO I (=pT1a1 L1, to Ib1 < 2cm)
Desire to have children
Possibility to obtain informed consent
Exclusion Criteria
Patients with multifocal tumours
Neuroendocrinological carcinoma / tumours
Invasion of small vessels (V1)
Pregnancy
History of other malignancies
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rates of Preterm Delivery <br>Follow-ups every 3 months postoperative for 2 years, after that every 6 months overall 5 years
- Secondary Outcome Measures
Name Time Method Disease-free Survival<br>Peri- and Postoperative Complication Rates<br>Quality of Life<br>Overall survival<br>Marker of recurrence<br>Follow-ups every 3 months postoperative for 2 years, after that every 6 months overall 5 years